Back to search results

Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease

Abroad (travel likely)RecruitingPHASE1

Conditions

Autosomal Dominant Polycystic Kidney Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Research Site, Birmingham, Alabama, United States

  • Research Site, Loma Linda, California, United States

  • Research Site, Jacksonville, Florida, United States

  • Research Site, Orlando, Florida, United States

  • Research Site, Lenexa, Kansas, United States

  • Research Site, Baltimore, Maryland, United States

  • Research Site, Rochester, Minnesota, United States

  • Research Site, San Antonio, Texas, United States

  • Research Site, Chengdu, China

  • Research Site, Hangzhou, China

  • Research Site, Nanjing, China

  • Research Site, Shanghai, China

  • Research Site, Wuhan, China

  • Research Site, Xiamen, China

  • Research Site, London, United Kingdom

View source on ClinicalTrials.gov(opens in a new tab)